Earnings · China A-shares
Guizhou Yibai Pharmaceutical Co. Ltd. Class A (600594) earnings
Guizhou Yibai Pharmaceutical Co. Ltd. Class A published its Q3 report on 2026-10-30: net profit -74.73% year on year, -92.44% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +1.25% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-30
- Period end
- 2026-09-30
- Net profit YoY
- -74.73%
- Excl. one-offs YoY
- -92.44%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.31% | — |
| 3 days | +1.25% | — |
| 7 days | +0.00% | — |
| 14 days | -7.52% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 4 of 6 reports (average -0.46%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-31 | -¥151.25M | -74.73% | -92.44% | -31.57% | -0.19 | -7.16% | +1.25% | — | — |
| 2026 interim report | 2026-08-21 | -¥80.34M | -303.67% | — | -30.58% | -0.10 | -3.74% | -1.03% | -5.15% | +0.55% |
| 2026 Q1 report | 2026-04-23 | -¥29.52M | -214.57% | — | -28.44% | -0.04 | -1.36% | -10.74% | -29.47% | -27.92% |
| 2025 annual report | 2026-04-23 | -¥329.56M | -3.89% | -0.59% | -14.31% | -0.42 | -14.18% | -10.74% | -29.47% | -27.92% |
| 2025 Q3 report | 2025-10-30 | -¥86.56M | +48.83% | +52.99% | -15.59% | -0.11 | -3.54% | +1.90% | -3.56% | +1.18% |
| 2025 interim report | 2025-08-21 | -¥19.90M | +81.31% | +72.15% | -14.99% | -0.03 | -0.80% | +2.64% | -10.33% | -21.01% |
| 2025 Q1 report | 2025-04-26 | -¥9.39M | +86.29% | +77.87% | -12.43% | -0.01 | -0.38% | +3.23% | +19.35% | +16.11% |
| 2024 annual report | 2025-04-26 | -¥317.22M | -406.79% | — | -22.92% | -0.40 | -11.78% | +3.23% | +19.35% | +16.11% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.